Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-001684-11Phase 2Completed
Phase 2, open-label, single-arm trial of l-Menthol in Neuralgia, sponsored by University of Edinburgh. Primary endpoint: Clinical pain response at 4 to 6 weeks. Started Apr 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-001684-11.